133 related articles for article (PubMed ID: 33369622)
1. Onychomycosis caused by the environmental mold Neoscytalidium dimidiatum in Colombia, and in vitro antifungal susceptibility evaluation.
Gil-González M; Gómez-Velásquez JC; Loaiza-Díaz N; Florez-Muñoz SV; Hernández-Herrera GN; Mesa-Arango AC
Med Mycol; 2020 Dec; ():. PubMed ID: 33369622
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of 5% amorolfine nail lacquer in Neoscytalidium dimidiatum onychomycosis.
Bunyaratavej S; Leeyaphan C; Rujitharanawong C; Surawan TM; Muanprasat C; Matthapan L
J Dermatolog Treat; 2016 Aug; 27(4):359-63. PubMed ID: 26471716
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for mycological cure in patients with onychomycosis caused by Neoscytalidium dimidiatum: A retrospective cohort study.
Leeyaphan C; Chai-Adisaksopha C; Tovanabutra N; Phinyo P; Bunyaratavej S
Mycoses; 2023 Jun; 66(6):497-504. PubMed ID: 36740753
[TBL] [Abstract][Full Text] [Related]
4. ITS rDNA Gene Analysis Versus MALDI-TOF MS For Identification of
Flórez-Muñoz SV; Gómez-Velásquez JC; Loaiza-Díaz N; Soares C; Santos C; Lima N; Mesa-Arango AC
Microorganisms; 2019 Sep; 7(9):. PubMed ID: 31480602
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Antifungal Susceptibility of Neoscytalidium dimidiatum Clinical Isolates from Malaysia.
James JE; Santhanam J; Lee MC; Wong CX; Sabaratnam P; Yusoff H; Tzar MN; Razak MF
Mycopathologia; 2017 Apr; 182(3-4):305-313. PubMed ID: 27815659
[TBL] [Abstract][Full Text] [Related]
6. Onychomycosis: clinical, mycological and in vitro susceptibility testing of isolates of Trichophyton rubrum.
Azambuja CV; Pimmel LA; Klafke GB; Xavier MO
An Bras Dermatol; 2014; 89(4):581-6. PubMed ID: 25054744
[TBL] [Abstract][Full Text] [Related]
7. First Isolation of Neoscytalidium dimidiatum from Human Dermatomycosis in Japan.
Futatsuya T; Ogawa A; Anzawa K; Mochizuki T; Shimizu A
Med Mycol J; 2022; 63(3):71-75. PubMed ID: 36047185
[TBL] [Abstract][Full Text] [Related]
8. Laser treatment of onychomycosis due to Neoscytalidium dimidiatum: An open prospective study.
Leverone AP; Guimarães DA; Bernardes-Engemann AR; Orofino-Costa R
Med Mycol; 2018 Jan; 56(1):44-50. PubMed ID: 28472375
[TBL] [Abstract][Full Text] [Related]
9. Trichophyton rubrum DNA strain switching increases in patients with onychomycosis failing antifungal treatments.
Gupta AK; Nakrieko KA
Br J Dermatol; 2015 Jan; 172(1):74-80. PubMed ID: 24903451
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
[TBL] [Abstract][Full Text] [Related]
11. Neoscytalidium dimidiatum as onychomycosis causative agent in an Iranian patient: a case report and literature review.
Razavyoon T; Hashemi SJ; Ansari S; Mansouri P; Daie-Ghazvini R; Khodavaisy S; Rafat Z; Kamali Sarvestani H; Hosseinpour L; Afshar P; Hashemi F; Safaie F
New Microbes New Infect; 2022 Jan; 45():100952. PubMed ID: 35251666
[TBL] [Abstract][Full Text] [Related]
12. Allergic fungal rhinosinusitis caused by Neoscytalidium dimidiatum: A case report: Allergic fungal rhinosinusitis due to Neoscytalidium dimidiatum.
Raiesi O; Hashemi SJ; Yarahmadi M; Getso MI; Raissi V; Amiri S; Borjian Boroujeni Z
J Mycol Med; 2022 Mar; 32(1):101212. PubMed ID: 34758426
[TBL] [Abstract][Full Text] [Related]
13. Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.
Bradley MC; Leidich S; Isham N; Elewski BE; Ghannoum MA
Mycoses; 1999; 42 Suppl 2():105-10. PubMed ID: 10865915
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary Fungal Infection Caused by Neoscytalidium dimidiatum.
Dionne B; Neff L; Lee SA; Sutton DA; Wiederhold NP; Lindner J; Fan H; Jakeman B
J Clin Microbiol; 2015 Jul; 53(7):2381-4. PubMed ID: 25948605
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
Jo Siu WJ; Tatsumi Y; Senda H; Pillai R; Nakamura T; Sone D; Fothergill A
Antimicrob Agents Chemother; 2013 Apr; 57(4):1610-6. PubMed ID: 23318803
[TBL] [Abstract][Full Text] [Related]
16. Molecular typing and antifungal susceptibility of Trichophyton rubrum isolates from patients with onychomycosis pre- and post-treatment.
de Assis Santos D; de Carvalho Araújo RA; Kohler LM; Machado-Pinto J; Hamdan JS; Cisalpino PS
Int J Antimicrob Agents; 2007 May; 29(5):563-9. PubMed ID: 17331707
[TBL] [Abstract][Full Text] [Related]
17. Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.
Bradley MC; Leidich S; Isham N; Elewski BE; Ghannoum MA
Mycoses; 1999 Dec; 42 Suppl 2():105-110. PubMed ID: 29265615
[TBL] [Abstract][Full Text] [Related]
18. Onychomycosis by Scytalidium dimidiatum in green tea leaf pluckers: report of two cases.
Barua P; Barua S; Borkakoty B; Mahanta J
Mycopathologia; 2007 Oct; 164(4):193-5. PubMed ID: 17641983
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibilities of Neoscytalidium spp. sequence types to antifungal agents and antimicrobial photodynamic treatment with phenothiazinium photosensitizers.
Tonani L; Morosini NS; Dantas de Menezes H; Nadaletto Bonifácio da Silva ME; Wainwright M; Leite Braga GÚ; Regina von Zeska Kress M
Fungal Biol; 2018 Jun; 122(6):436-448. PubMed ID: 29801787
[TBL] [Abstract][Full Text] [Related]
20. Onychomycosis in Cameroon: a clinical and epidemiological study among dermatological patients.
Nkondjo Minkoumou S; Fabrizi V; Papini M
Int J Dermatol; 2012 Dec; 51(12):1474-7. PubMed ID: 23171013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
